FDA doubles down on rejecting over-the Counter CBD
FDA doubles down on rejecting over-the-counter CBD without more study Federal food and drug regulators on Tuesday addressed the latest hemp industry directly for the first time since stakeholders asked for feedback regarding CBD safety back in 2019.But the message was a familiar one. Grail Sipes, acting cannabis-product committee chair with the U.S. Food and Drug Administration, reiterated …
FDA doubles down on rejecting over-the Counter CBD Read More »
